Navigation Links
Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain
Date:11/10/2010

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, New Products & Services Click to view news release full screen  

Neuro-Biotech Corp. Neuroceuticals® : A solution to feed the brain

 

BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)

Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.

According with our licences, we have a portfolio of four (4) innovative and selective products.

  • Neuro-Relax®
    A protein based supplement that favours the sleep's quality, decreases the anxiety and nervous pressure, improves general anxiety, anxious disorders, physical, emotional and mental stress and has a tranquilizing and soothing effect
  • Neuro-Learn®
    An adaptogene that helps stimulating the noradregenic and cholinergic systems resulting in improvement with memory, depression, concentration, attention and vigilance in particular with children suffering from attention deficit disorder which often need treatment with methylphenidate, among others marketed under the name of Ritalin®.
  • Neuro-Stim®
    An adoptogene which effect results in an increase in energy in order to reduce the effects of depression, hypoglycaemia, stress, obesity and type II diabetes as well as food behaviour's disorders such as bulimia.
  • Neuro-Lean®
    A product specially conceived to help with weight-loss management, optimizing the energetic spending as well as maintaining body weight.
  • Those four (4) products will be sold and distributed by many means; directly from us under our own label as well as through "Private labels" such as pharmacies, megastore and natural products brands. Since we are actively in a negotiation process, it will be the distributor's mandate, in terms of their respective part of the market, to target the clientele they believe should be reached.

    For more detailed information on the scientific data and the Neuroceuticals®, we invite you to consult our website at neuro-biotechcorp.com under the products section.

    Neuro-Biotech is currently negotiating with 2 separates groups on the East coast and West coast for them to distribute the Neuroceuticals®. Management also decided that in order to maximize the market penetration and based on the product composition, it was it the Company's best interest to categorize the Neuroceuticals® as Natural Products and Food Supplements.

    For more information, do not hesitate to contact us by using the contact form on our corporate website at neuro-biotechcorp.com. Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.


    '/>"/>
    SOURCE Neuro-Biotech Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Mr Claude Poulin nominated as President and CEO of Neuro-Biotech Corp.
    2. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
    3. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
    4. NEURO-BIOTECH CORPORATION: Updates and latest developments
    5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
    6. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
    7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
    8. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
    9. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
    10. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
    11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/16/2017)... OXFORD, England , Aug. 16, 2017 /PRNewswire/ ... biotech executive search and leadership development, and Virdis Group, global ... created an exclusive alliance that enables clients to leverage the ... "For our clients here in the ... to a diverse population of leadership talent throughout the US, ...
    (Date:8/15/2017)... ... 2017 , ... Any expert in stem cell research or stem cell medicine ... half a century. Despite their essential roles in human health and regenerative medicine, ... tags developed for this purpose also tag other, more abundant, non-stem tissue cells ( ...
    (Date:8/14/2017)... (PRWEB) , ... August 14, 2017 , ... ... characterized and performing antibodies. Key researchers in the antibody community have recently come ... and consistency for antibodies in the laboratory. , The team at ...
    (Date:8/11/2017)... ... August 11, 2017 , ... Algenist continues to disrupt the skincare industry with ... before. , Collagen is the key structural element skin needs to maintain its ... include: , First to market with proprietary collagen water ...
    Breaking Biology Technology:
    (Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
    (Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
    (Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
    Breaking Biology News(10 mins):